Living with PNH
Living with Paroxysmal nocturnal hemoglobinuria (PNH) can be challenging for the person with the condition and their caregivers.
Learn more
Adverse Event Reporting

Please report any adverse events via your national reporting system. Adverse events can also be reported to Alexion, AstraZeneca Rare Disease by contacting: https://contactazmedical.astrazeneca.com/

Brodsky R.A. Paroxysmal Nocturnal Hemoglobinuria. Best Principles and Practice. Chapter 31. Hematology. 2018:415-424. Hill A, et al. Paroxysmal Nocturnal Haemoglobinuria. Nature Reviews Disease Primers. 2017. Szlendak U, Budziszewska B, Spychalska J, et al. Paroxysmal nocturnal hemoglobinuria: advances in the understanding of pathophysiology, diagnosis, and treatment. Pol Arch Intern Med 2022;132:16271. Spencer-Tansley. et al. Mental health care for rare disease in the UK – recommendations from a quantitative survey and multi-stakeholder workshop. BMC Health Services Res. 2022;22:648. Schrezenmeier H, Muus P, Socié G, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99(5):922-929. advance I am a healthcare professional registered in the EU I am not a
healthcare professional